A recent study of antilatex IgE antibodies in blood donors has shown the prevalence of latex sensitivity may be as high as 6-12%1 or up to 37 million people in the U.S. alone.
Latex allergy or hypersensitivity occurs when the body's immune system reacts to proteins found in natural rubber latex. A Type I systemic reaction is an immediate hypersensitivity reaction moderated by the development of IgE antibodies to specific proteins in latex, causing a serious and potentially lethal event. Once sensitized, most individuals are asymptomatic and unaware of their antibody status,1,2 therefore clinicians cannot assume that any patient is free of latex allergy.
We are dedicated to increasing clinical awareness of the potential risks of latex products, and as a result, we provide clinicians with a full line of pulmonary artery catheters and central venous catheters offered with no natural rubber latex components.
Our extensive portfolio of critical care catheters with no natural rubber latex components covers the full spectrum of patient acuity without compromising performance.
- Lebenbom-Mansour MH, Oesterle JR, Ownby DR, et al. The incidence of latex sensitivity in ambulatory surgical patients: a correlation of historical factors with positive serum immunoglobulin E levels. Anesth Analg 1997; 85: 44-9
- Page EH, Esswein EJ. NIOSH health hazard evaluation report. HETA 98-0096-2737 Exempla St. Jospeh Hospital. Cincinnati, OH: National Institute of Occupational Safety and Health 1198:1-25